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Rift Valley Fever
Virus Infection
among French
Troops in Chad
To the Editor: During the rainy
season every year, outbreaks of self-
limiting nonmalarious febrile syn-
dromes have occurred in French mili-
tary troops on duty in Chad. To deter-
mine the cause of these syndromes,
the Tropical Medicine Institute of the
French Army Medical Corps imple-
mented an arbo-virus surveillance
program in Marseille. 
During summer 2001, we collected
samples from 50 soldiers who had a
febrile illness. All blood spot samples
tested negative by enzyme-linked
immunosorbent assay (ELISA) for
certain antigens (i.e., dengue virus,
West Nile virus, Chikungunya virus,
and Wesselsbron virus). However,
after co-culture of 31 peripheral blood
lymphocyte samples with C6/36 and
Vero cell lines collected in
NDjamena, Chad, in August to
September 2001, two strains of Rift
Valley fever virus (RVFV) were iso-
lated and identified by using indirect
immunofluorescence with a specific
mouse ascitic fluid and by using
reverse transcriptase-polymerase
chain reaction (RT-PCR) and
sequencing. In retrospective testing,
we found that all serum specimens
tested by ELISA for RVFV-specific
immunoglobulin (Ig) M and IgG were
negative. The second serum samples
from the two case-patients with these
strains, collected 2 months later, were
strongly positive (IgM 1/200,000; IgG
1/5,000). 
Rift Valley fever, a febrile disease
that affects livestock and humans, is
transmitted by mosquitoes and caused
by a virus (genus: Phlebovirus, fami-
ly: Bunyaviridae) that can persist in
nature in contaminated eggs. The
virus was first isolated in Kenya in
1930 (1) and is endemic in the region.
In Chad, the disease was first reported
in 1967 at the same time as in
Cameroon (2); no strain was isolated
at that time. Since 1977, RVFV infec-
tion resulted in 600 deaths in Egypt
(3), 300 in Mauritania in 1987 (4), and
200 in Saudi Arabia and Yemen (5,6)
in 2000 to 2001. 
To characterize these RVFV
strains, parts of the three genome seg-
ments (L, M, and S) were amplified
by using RT-PCR and sequenced as
described (7,8). The figure shows the
phylogenic tree constructed from the
sequence of the region coding for NSs
in the S segment, by using the neigh-
bor-joining method implemented in
Clustal W (version 1.6; available
from: URL: http://www-igbmc.u-
strasbg.fr/BioInfo/ClustalW/clustalw.
html). The two strains identified in
Chad are quite similar. They are locat-
ed within the East/Central lineage
established previously (6,7), which
contains the virus that circulated in
Madagascar (1991), Kenya (1997–
1998), and Yemen and Saudi Arabia
(2000–2001) (9,10). Sequencing of
the region in the M and L segments
led to the same clustering (not shown),
suggesting that this virus did not
evolve by reassortment. Deter-mining
the origin of the virus is difficult, but
its genetic properties suggest that this
strain has a Kenyan origin. Before this
isolation, no RVFV strains from Chad
had been genetically characterized.
This strain may be endemic in this
region of Central Africa, or the RVFV
strain circulating in the Eastern coun-
tries may have been transported out-
side of the territory (which was likely
the case in Yemen and Saudi Arabia in
Figure. NSs-based phylogenetic tree of Rift Valley fever virus strains. Values indicate the
bootstrap support of the nodes. Strains isolated in Chad are designated H1CHA01 and
H2CHA01, according to the previous abbreviation guidelines (7,8). EMBL accession nos.
AJ504997 and AJ504998. SNS, Smithburn strain. Branch lengths are proportional to the
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2000) (9,10). Of the two case-patients,
one soldier did not leave NDjamena
during his 3-month tour of duty,
whereas the other had been in contact
with livestock in a flooded area before
onset of symptoms. Contamination
may have occurred through infected
animals or mosquitoes, although
sheep living in the area did not show
any sign of disease (i.e., spontaneous
abortions, deaths). The two cases we
describe were self-limiting; however,
deaths from this illness have been
reported in nonepidemic settings in
Central African Republic (11). Our
data emphasize that healthcare
providers should systematically con-
sider Rift Valley fever as a diagnosis
for febrile syndromes in persons
returning from Africa, even in nonepi-
demic settings (12).
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Corynebacterium
ulcerans Diphtheria
in Japan 
To the Editor:  Corynebacterium
ulcerans causes a zoonotic infection
similar to diphtheria, which is caused
by  C. diphtheriae. Studies indicate
that signs and symptoms of a diphthe-
ria-like illness caused by C. ulcerans
are milder than those caused by C.
diphtheriae. However, some strains of
C. ulcerans produce potent diphtheria
toxin and may cause severe symptoms
similar to those caused by C. diphthe-
riae (1). We report a case of a diphthe-
ria-like illness caused by C. ulcerans
infection.
A previously healthy 52-year-old
woman first noticed hoarseness
approximately 3 days before admis-
sion to the hospital. On February 16,
2001, severe dyspnea and fever devel-
oped, and the patient was referred to
the emergency room of the Asahi
General Hospital by her private prac-
titioner. Physical examination indicat-
ed a large stridor, which could be
heard without using a stethoscope.
Cyanosis was not observed. The
endoscopic examination showed a
thick white coat covering the
nasopharynx and laryngeal vestibu-
lum, and subglottic constriction was
also observed. A chest x-ray showed
diffuse infiltrates in both lungs.
Pertinent laboratory findings on
admission included leukocyte count
of 16.8 x 103/µL and C-reactive pro-
tein of 20.0 mg/dL. The serum level
of liver transaminase was normal, and
both Wassermann reaction and anti-
HIV antibody tests were negative.
Pharyngolaryngitis and pneumonia
was diagnosed in the patient. Because
of severe dyspnea, intubation was per-
formed, which caused sudden and
unexpected exacerbation of the condi-
tion. Severe cyanosis subsequently
developed. Extubation was immedi-
ately performed, and a thick white
material was found to be filling the
lumen of the endotracheal tube.
Reintubation was performed, and dys-
pnea subsided. The patient was hospi-
talized in the intensive-care unit.
Sulbactam sodium/ampicillin sodium
(6 g per day) was intravenously
administered for 4 days; however, the
symptoms were not much improved.
The symptoms were most consistent
with those of diphtheria. Therefore,
the patient was subsequently placed